MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Racial and ethnic differences in patients with Parkinson’s Disease across Parkinson’s Disease Centers of Excellence

    D. Di Luca, S. Luo, T. Davis, A. Ramirez-Zamora, M. Rafferty, N. Dahodwala, C. Marras (Toronto, Canada)

    Objective: To investigate treatment, health-related quality of life, and other outcome differences in patients with Parkinson’s Disease (PD) across race and ethnicity. Background: The inclusion…
  • MDS Virtual Congress 2021

    Clinical and Economic Outcomes Associated with Dysphagia in Hospitalized Patients with Parkinson’s Disease

    D. Di Luca, E. Mcarthur, A. Willis, R. Martino, C. Marras (Toronto, Canada)

    Objective: To evaluate the outcomes associated with dysphagia in hospitalized patients with Parkinson's Disease and associated healthcare costs and utilization. Background: Dysphagia in Parkinson's Disease…
  • MDS Virtual Congress 2021

    Optimizing an Electronic Health Records (EHR)-based Algorithm for Parkinson’s Disease Case Ascertainment

    A. Duarte Folle, L. Uhr, F. Agosta, T. Chang, C. Baddley, B. Ritz, C. Tanner, A. Wu, A. Wilson (Los Angeles, USA)

    Objective: To develop an EHR-based algorithm to classify patients with PD into three levels of diagnostic certainty. Background: EHRs can be a rich source of…
  • MDS Virtual Congress 2021

    Clinical epidemiology of movement disorders in Douala General Hospital, Cameroon: A two years retrospective study

    D. Gams Massi, AM. Magnerou, G. Tchumno Mayoue, EA. Babe, NY. Mapoure (Douala, Cameroon)

    Objective: The aim of this study was to determine the frequency of movement disorders and their characteristics in the outpatient department of neurology at the…
  • MDS Virtual Congress 2021

    Application of the updated MDS criteria for prodromal Parkinson’s disease to a population-based 10-year study

    K. Marini, K. Seppi, L. Tschiderer, S. Kiechl, H. Stockner, P. Willeit, J. Willeit, A. Djamshidian, G. Rungger, W. Poewe, P. Mahlknecht (Innsbruck, Austria)

    Objective: We aimed to identify differences and analyze the potential added value of the updated Movement Disorders Society (MDS) research criteria for prodromal Parkinson’s disease…
  • MDS Virtual Congress 2021

    Patient-Reported Impact of Standard-of-Care: Change in Symptoms Following Dopamine Initiation and Deep Brain Stimulation

    L. Mischley, C. Weaver, J. Farahnik, Y. Chien (Kenmore, USA)

    Objective: The goal of this study was to describe changes in patient-reported symptoms following initiation of standard-of-care treatment strategies in Parkinson’s disease (PD). Background: A…
  • MDS Virtual Congress 2021

    Characteristics and outcomes of Parkinson’s disease individuals hospitalized with COVID-19 in a New York City hospital system

    L. Nwabuobi, C. Zhang, C. Henchcliffe, H. Shah, H. Sarva, A. Lee, H. Kamel (New York, USA)

    Objective: To determine the clinical characteristics and outcomes in hospitalized individuals with Parkinson's disease (PD) infected with COVID-19 Background: The COVID-19 pandemic has caused worse…
  • MDS Virtual Congress 2021

    PREVALENCE OF MOVEMENT DISORDERS AT A TERTIARY HEALTH CARE CENTRE IN ABUJA, NIGERIA

    N. Obianozie, G. Onwuegbuzie, P. Alabi, F. Abdulai (Gwagwalada, Nigeria)

    Objective: This study aims to describe the prevalence and sociodemographic characteristics of movement disorders seen at our Specialised Movement Disorder (MD) clinic at Abuja, Nigeria…
  • MDS Virtual Congress 2021

    The COVID-19 Pandemic Impact on Advanced Parkinson’s Disease in the US

    D. Oleske, S. Talapala, P. Kukreja, M. Facheris, R. Dorsey, S. Dey, A. Isherwood (North Chicago, USA)

    Objective: Characterize the risk of seven acute medical events in persons with advanced Parkinson’s disease (PD) using real world data before and within 12 months…
  • MDS Virtual Congress 2021

    Morbidity and mortality from neurodegenerative patients hospitalized with COVID-19 in the Chicagoland area

    R. Patel, G. Stebbins, B. Barton (Chicago, USA)

    Objective: To assess morbidity and mortality of acute COVID-19 infection in hospitalized patients with neurodegenerative diseases and compare with age-matched controls. Background: Outcomes from COVID-19…
  • « Previous Page
  • 1
  • …
  • 713
  • 714
  • 715
  • 716
  • 717
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley